+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biotechnology Services Market - Global Forecast to 2030- Product Image
Biotechnology Services Market - Global Forecast to 2030- Product Image
Sale

Biotechnology Services Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010910
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biotechnology Services Market grew from USD 214.69 billion in 2024 to USD 240.24 billion in 2025. It is expected to continue growing at a CAGR of 11.68%, reaching USD 416.75 billion by 2030.

The biotechnology services sector has emerged as a critical enabler of innovation across healthcare, pharmaceuticals and research. As organizations navigate increasingly complex regulatory requirements, adopt cutting-edge technologies and pursue strategic collaborations, demand for specialized services-ranging from regulatory consulting through contract research and advanced analytical testing-has surged. This executive summary offers a comprehensive overview of the forces reshaping this dynamic ecosystem, highlights key segmentation and regional dynamics and examines how recent tariff policies are altering trade flows and investment decisions. By synthesizing insights from end-users, service types and technology applications, readers will gain a clear understanding of the market’s current trajectory and the strategic opportunities poised to deliver competitive advantage.

Transformative Shifts Reshaping Service Offerings

Over the past decade the biotechnology services arena has undergone transformative shifts, driven by rapid technological advances, evolving regulatory frameworks and the growing emphasis on personalized medicine. Genomics platforms leveraging both long-read and short-read sequencing have matured to unlock unprecedented biological insights, while proteomics workflows-anchored in mass spectrometry and protein microarrays-are accelerating biomarker discovery and drug target validation. Simultaneously, bioinformatics solutions have become indispensable, blending sophisticated data analysis software with visualization tools to translate vast datasets into actionable intelligence. These developments have catalyzed new service models: strategic consulting teams now guide regulatory submissions with deep expertise in CRISPR and sequencing technologies, while contract manufacturing and research arms deliver end-to-end project execution for both early and advanced lifecycle stages. As diagnostic and therapeutic applications converge, the sector’s evolution underscores a fundamental shift from standalone services toward integrated, end-to-end partnerships that drive faster innovation cycles and enhanced patient outcomes.

Assessing the Impact of US Tariffs in 2025

The introduction of updated United States tariff measures in twenty-twenty-five has exerted a cumulative impact on cross-border sourcing of reagents, sequencing instruments and laboratory equipment. Supply chains reliant on imports have faced increased cost pressures, prompting service providers to reevaluate manufacturing footprints and diversify supplier networks. End-users within diagnostic laboratories and hospitals have sought to mitigate tariff-related expense increases by forging long-term procurement agreements and investing in domestic biobanking capacities. Simultaneously, pharmaceutical and biotech firms are rebalancing outsourcing portfolios: contract research organizations now explore near-shoring options to preserve project timelines and maintain regulatory compliance without sacrificing cost efficiencies. Ultimately, these tariff adjustments have accelerated strategic realignments, bolstered regional production clusters and intensified competition among service providers to secure resilient, compliant supply chains.

Key Insights from Market Segmentation

A detailed segmentation analysis reveals the nuanced demands driving service innovation and tailored value propositions across end-user categories, service lines, technologies and applications. Healthcare providers spanning clinics, diagnostic labs and hospitals are increasingly investing in strategic consulting to streamline regulatory pathways and in analytical testing capabilities to expand in-house diagnostics. Pharmaceutical companies-including both pioneering biotech firms and generic manufacturers-are engaging contract manufacturing and research partners to accelerate both lead optimization and target identification efforts. Academic research centers and private labs alike leverage biobanking and data analysis software, while growth-oriented startups and established enterprises seek multi-project agreements due to predictable delivery timelines. Within service portfolios, regulatory consulting has intertwined with strategic advisory, while analytical testing collaborates with mass spectrometry platforms and long-read sequencing to support advanced clinical trials and companion diagnostics development. Outsourcing services now span single-project contracts to subscription-based annual packages, ensuring sustained collaboration throughout preclinical studies, clinical trial execution and commercialization support. Across technology segments, bioinformatics and visualization tools enhance genomics workflows-from CRISPR design through short-read and long-read sequencing-and complement proteomics pipelines that employ protein microarrays to refine biomarker assays. Application areas including biomarker discovery, genetic testing, companion diagnostics and tailored therapies underscore the pivot toward personalized medicine. Meanwhile, licensing-based agreements for patent licensing and technology transfers coexist with project-based multi-project frameworks, offering flexibility to organizations at every lifecycle stage from early development research initiatives through late-stage regulatory approval processes.

Critical Regional Dynamics and Growth Drivers

Regional dynamics continue to shape competitive positioning and investment priorities. In the Americas, established hubs in North America maintain leadership through robust infrastructure, strong intellectual property protections and deep networks of academic and industry collaborations, while Latin American markets are emerging as cost-effective centers for biobanking and early-stage research. Europe, the Middle East and Africa benefit from harmonized regulatory guidelines across the European Union, fostering cross-border clinical trial consortia and bolstering contract research capabilities, even as compliance demands intensify. In Asia-Pacific, government incentives and rapid technology adoption drive expansion in sequencing facilities and bioinformatics service providers, particularly in markets centered on precision medicine and large-scale public health genomics initiatives. This geographic diversification not only enhances global service continuity but also opens avenues for strategic partnerships across established and emerging biotech clusters.

Overview of Leading Industry Participants

The competitive landscape features a roster of established industry leaders and agile emerging players that are shaping service innovation and value delivery. Some companies integrate contract research and manufacturing capabilities with advanced analytical platforms to create seamless end-to-end service ecosystems, while others specialize in niche areas-such as high-throughput sequencing or regulatory consulting-to differentiate their offerings. Major instrumentation and consumables suppliers are also expanding into service domains, leveraging distribution networks to bundle testing and advisory services. Collaborative alliances between biopharma clients and service providers drive joint development programs and co-innovation platforms. Strategic mergers and acquisitions have enabled organizations to broaden geographic reach, enhance technology portfolios and scale operational capacity. Ultimately, the interplay between full-service providers and specialized niche firms ensures a dynamic market where expertise, speed and regulatory acumen determine the leaders of tomorrow’s biotechnology services sector.

Actionable Recommendations for Service Providers

To navigate this complex environment, industry leaders should adopt a multi-pronged approach. First, they should deepen partnerships across the value chain by establishing integrated service agreements that link consulting, laboratory and outsourcing activities under a single governance framework. Second, organizations must invest in modular technology platforms-such as flexible sequencing systems and adaptable biobanking networks-that can pivot with evolving research priorities and regulatory requirements. Third, service providers should diversify supply chains by cultivating strategic supplier alliances and near-shore manufacturing facilities to minimize exposure to tariff fluctuations. Fourth, companies can unlock new growth by developing subscription-based models and annual packages that deliver predictable revenue streams and foster long-term client loyalty. Finally, decision-makers must prioritize talent development, embedding cross-functional teams of regulatory experts, data scientists and project managers to drive seamless project execution across early and advanced lifecycle stages.

Conclusion and Strategic Imperatives

Innovation in biotechnology services is at an inflection point. The convergence of advanced sequencing, proteomics and bioinformatics, together with evolving trade policies and shifting regional priorities, requires organizations to be both agile and collaborative. By leveraging integrated service models, technology-driven platforms and resilient supply chain strategies, industry participants can unlock new efficiencies and accelerate research-to-market timelines. As patient-centric approaches gain momentum, the ability to deliver tailored diagnostic and therapeutic solutions will distinguish market leaders and create sustainable competitive advantage.

Market Segmentation & Coverage

This research report categorizes the Biotechnology Services Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Healthcare Providers
    • Clinics
    • Diagnostic Labs
    • Hospitals
  • Pharmaceutical Companies
    • Biotech Firms
    • Generic Manufacturers
  • Research Institutions
    • Academic Research Centers
    • Private Research Labs
  • Consulting Services
    • Regulatory Consulting
    • Strategic Consulting
  • Laboratory Services
    • Analytical Testing
    • Biobanking
  • Outsourcing Services
    • Contract Manufacturing
    • Contract Research
  • Bioinformatics
    • Data Analysis Software
    • Visualization Tools
  • Genomics
    • CRISPR Technology
    • Sequencing Technologies
      • Long-Read Sequencing
      • Short-Read Sequencing
  • Proteomics
    • Mass Spectrometry
    • Protein Microarrays
  • Diagnostics
    • Biomarker Discovery
    • Genetic Testing
  • Drug Discovery
    • Lead Optimization
    • Target Identification
  • Personalized Medicine
    • Companion Diagnostics
    • Tailored Therapies
  • Licensing-Based
    • Patent Licensing
    • Technology Transfers
  • Project-Based
    • Multi-Project Agreements
    • Single Project Contracts
  • Subscription-Based
    • Annual Packages
    • Monthly Plans
  • Large Enterprises
  • Small And Medium Enterprises
    • Growth Companies
    • Startups
  • Advanced Development
    • Clinical Trials
    • Regulatory Approval Process
  • Early Development
    • Preclinical Studies
    • Research & Development Initiatives
  • Diagnostics
    • Clinical Chemistry Systems
    • Imaging Products
  • Therapeutics
    • Biologics
    • Small Molecules

This research report categorizes the Biotechnology Services Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biotechnology Services Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Agilent Technologies, Inc.
  • Almac Group Limited
  • AnaBioTec NV
  • Avance Clinical Pty Ltd.
  • Azenta Life Sciences
  • Becton, Dickinson and Company
  • Biogen Inc.
  • BioIVT LLC
  • Caidya
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • CMIC Group
  • Contract Pharmacal Corp.
  • Crown Bioscience, Inc.
  • Danaher Corporation
  • Eurofins Scientific Limited
  • GE HealthCare Technologies Inc.
  • GenScript Biotech Corporation
  • ICON PLC
  • ITR Laboratories Canada
  • Kaneka Corporation
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Novartis AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biotechnology Services Market, by End-User
8.1. Introduction
8.2. Healthcare Providers
8.2.1. Clinics
8.2.2. Diagnostic Labs
8.2.3. Hospitals
8.3. Pharmaceutical Companies
8.3.1. Biotech Firms
8.3.2. Generic Manufacturers
8.4. Research Institutions
8.4.1. Academic Research Centers
8.4.2. Private Research Labs
9. Biotechnology Services Market, by Service Type
9.1. Introduction
9.2. Consulting Services
9.2.1. Regulatory Consulting
9.2.2. Strategic Consulting
9.3. Laboratory Services
9.3.1. Analytical Testing
9.3.2. Biobanking
9.4. Outsourcing Services
9.4.1. Contract Manufacturing
9.4.2. Contract Research
10. Biotechnology Services Market, by Technology
10.1. Introduction
10.2. Bioinformatics
10.2.1. Data Analysis Software
10.2.2. Visualization Tools
10.3. Genomics
10.3.1. CRISPR Technology
10.3.2. Sequencing Technologies
10.3.2.1. Long-Read Sequencing
10.3.2.2. Short-Read Sequencing
10.4. Proteomics
10.4.1. Mass Spectrometry
10.4.2. Protein Microarrays
11. Biotechnology Services Market, by Application
11.1. Introduction
11.2. Diagnostics
11.2.1. Biomarker Discovery
11.2.2. Genetic Testing
11.3. Drug Discovery
11.3.1. Lead Optimization
11.3.2. Target Identification
11.4. Personalized Medicine
11.4.1. Companion Diagnostics
11.4.2. Tailored Therapies
12. Biotechnology Services Market, by Business Model
12.1. Introduction
12.2. Licensing-Based
12.2.1. Patent Licensing
12.2.2. Technology Transfers
12.3. Project-Based
12.3.1. Multi-Project Agreements
12.3.2. Single Project Contracts
12.4. Subscription-Based
12.4.1. Annual Packages
12.4.2. Monthly Plans
13. Biotechnology Services Market, by Customer Size
13.1. Introduction
13.2. Large Enterprises
13.3. Small And Medium Enterprises
13.3.1. Growth Companies
13.3.2. Startups
14. Biotechnology Services Market, by Lifecycle Stage
14.1. Introduction
14.2. Advanced Development
14.2.1. Clinical Trials
14.2.2. Regulatory Approval Process
14.3. Early Development
14.3.1. Preclinical Studies
14.3.2. Research & Development Initiatives
15. Biotechnology Services Market, by End-Product
15.1. Introduction
15.2. Diagnostics
15.2.1. Clinical Chemistry Systems
15.2.2. Imaging Products
15.3. Therapeutics
15.3.1. Biologics
15.3.2. Small Molecules
16. Americas Biotechnology Services Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Biotechnology Services Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Biotechnology Services Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Agilent Technologies, Inc.
19.3.2. Almac Group Limited
19.3.3. AnaBioTec NV
19.3.4. Avance Clinical Pty Ltd.
19.3.5. Azenta Life Sciences
19.3.6. Becton, Dickinson and Company
19.3.7. Biogen Inc.
19.3.8. BioIVT LLC
19.3.9. Caidya
19.3.10. Catalent, Inc.
19.3.11. Charles River Laboratories International, Inc.
19.3.12. CMIC Group
19.3.13. Contract Pharmacal Corp.
19.3.14. Crown Bioscience, Inc.
19.3.15. Danaher Corporation
19.3.16. Eurofins Scientific Limited
19.3.17. GE HealthCare Technologies Inc.
19.3.18. GenScript Biotech Corporation
19.3.19. ICON PLC
19.3.20. ITR Laboratories Canada
19.3.21. Kaneka Corporation
19.3.22. Laboratory Corporation of America Holdings
19.3.23. Merck KGaA
19.3.24. Novartis AG
19.3.25. Siemens Healthcare GmbH
19.3.26. Thermo Fisher Scientific Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. BIOTECHNOLOGY SERVICES MARKET MULTI-CURRENCY
FIGURE 2. BIOTECHNOLOGY SERVICES MARKET MULTI-LANGUAGE
FIGURE 3. BIOTECHNOLOGY SERVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. BIOTECHNOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. BIOTECHNOLOGY SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOTECHNOLOGY SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PRIVATE RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY STRATEGIC CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOBANKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY VISUALIZATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LONG-READ SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SHORT-READ SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEIN MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TAILORED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LICENSING-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PATENT LICENSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY TRANSFERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LICENSING-BASED, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROJECT-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY MULTI-PROJECT AGREEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SINGLE PROJECT CONTRACTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY ANNUAL PACKAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY MONTHLY PLANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY GROWTH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY STARTUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY ADVANCED DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGULATORY APPROVAL PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY ADVANCED DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY EARLY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT INITIATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY EARLY DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY IMAGING PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY LICENSING-BASED, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY ADVANCED DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY EARLY DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY LICENSING-BASED, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY ADVANCED DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY EARLY DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LICENSING-BASED, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY ADVANCED DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY EARLY DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 187. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 189. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 190. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 191. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 192. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
TABLE 193. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 194. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 195. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 197. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 198. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 199. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 200. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 202. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 203. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 204. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 205. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY LICENSING-BASED, 2018-2030 (USD MILLION)
TABLE 206. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2030 (USD MILLION)
TABLE 207. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2030 (USD MILLION)
TABLE 208. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2018-2030 (USD MILLION)
TABLE 209. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 210. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 211. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY ADVANCED DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 212. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY EARLY DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 213. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 215. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 216. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 218. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 219. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 220. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 221. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
TABLE 222. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 223. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 224. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 226. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 227. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 228. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 229. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 231. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 232. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 233. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 234. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY LICENSING-BASED, 2018-2030 (USD MILLION)
TABLE 235. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2030 (USD MILLION)
TABLE 236. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2030 (USD MILLION)
TABLE 237. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2018-2030 (USD MILLION)
TABLE 238. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 239. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 240. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY ADVANCED DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 241. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY EARLY DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 242. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 244. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 252. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 255. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 256. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 257. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 258. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 260. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 261. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 262. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 263. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY LICENSING-BASED, 2018-2030 (USD MILLION)
TABLE 264. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2030 (USD MILLION)
TABLE 265. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2030 (USD MILLION)
TABLE 266. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2018-2030 (USD MILLION)
TABLE 267. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 268. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 269. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY ADVANCED DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 270. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY EARLY DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 271. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 273. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 274. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 286. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 288. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 290. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 291. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 292. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY LICENSING-BASED, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY CUSTOMER SIZE, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY LIFECYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY ADVANCED DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY EARLY DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 312. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY OUTSOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 313. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 315. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 316. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SEQUENCING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 317. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 318. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 320. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 321. AUSTRALIA BIOTECHNOLOGY SERVICES

Companies Mentioned

  • Agilent Technologies, Inc.
  • Almac Group Limited
  • AnaBioTec NV
  • Avance Clinical Pty Ltd.
  • Azenta Life Sciences
  • Becton, Dickinson and Company
  • Biogen Inc.
  • BioIVT LLC
  • Caidya
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • CMIC Group
  • Contract Pharmacal Corp.
  • Crown Bioscience, Inc.
  • Danaher Corporation
  • Eurofins Scientific Limited
  • GE HealthCare Technologies Inc.
  • GenScript Biotech Corporation
  • ICON PLC
  • ITR Laboratories Canada
  • Kaneka Corporation
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Novartis AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Biotechnology Market Report by Product Type, Technology, Application, and Region 2025-2033 - Product Image

Biotechnology Market Report by Product Type, Technology, Application, and Region 2025-2033

  • Report
  • 138 Pages
  • Global
From
Biotechnology Market in the US 2025-2029 - Product Image

Biotechnology Market in the US 2025-2029

  • Report
  • 170 Pages
  • United States
From
Biotechnology for the Non-Biotechnologist Training Course (November 10-14, 2025) - Product Image

Biotechnology for the Non-Biotechnologist Training Course (November 10-14, 2025)

  • Training
  • 5 Days
  • Global
Biotechnology & Pharmaceutical Services Outsourcing Market - Global Forecast to 2030 - Product Image

Biotechnology & Pharmaceutical Services Outsourcing Market - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Biotechnology and Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report by Service (Consulting, Auditing & Assessment), End-use (Pharmaceutical Companies, Biotech Companies), Region, and Segment Forecasts, 2024-2030 - Product Image

Biotechnology and Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report by Service (Consulting, Auditing & Assessment), End-use (Pharmaceutical Companies, Biotech Companies), Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.